Matthew Heppel retweeted
With an explosion of medications like SGLT2i and GLP-1 analogues?
An excellent piece of work via @ABCDiab @Assoc_Anaes @RCoANews @UKCPA around peri-op management of adults on these meds
Use & cascade please
cc @kamleshkhunti @GoggleDocs @NeilFlochMD
associationofanaesthetists-p…
Matthew Heppel retweeted
Fergus presenting his important work making insulins safely and quickly available to patients in Leeds EDs @LeedsHospitals @LTHPharmacy #cpcongress
Matthew Heppel retweeted
📢If you call them, will they come? Factors influencing the retention of #pharmacy staff in UK healthcare settings
What we found:
📢Those who have value of & opportunity in professional practice are less likely to quit job, leave the profession & have greater job satisfaction....
Matthew Heppel retweeted
👉 Results SURMOUNT-3
🔹#tirzepatide vs placebo - over 72/52 in #obesity
🔸after 12/52 Intensive Lifestyle Intervention lead-in (#LCD + exercise + weekly counselling)
🔹6.9% ⤵️weight in lead-in
👉tirezepatide further ⤵️ 21.1% #WeightLoss 💪
👉placebo ⤴️ 3.3% weight
🔗 investor.lilly.com/news-rele…
@kamleshkhunti @LillyPadEU @AskDrShashank @Dralbalawi1989
Matthew Heppel retweeted
Great day celebrating #inpatient Diabetes care #DCAPlaunch with the inspiring @PaulaJDSN!
Kudos 👏 to:
➡️ project management team (Daniel Flanagan, @EstherWalden2, Eva Lynch, Klea Isufi)
➡️ pilot sites
➡️ Multidisciplinary assessment team including PLWD
➡️ @JBDSIP @NHSGIRFT
Matthew Heppel retweeted
Orforglipron #ADA2023 .. daily oral GLP-1
🤜can be taken without restriction of food, water, other meds.. non peptide
🤜14.7% weight loss at 36weeks
Matthew Heppel retweeted
Paper alert! #obesity #T2DM
🩸📉 CagriSema ⬆ HbA1c reduction (-2.2%) compared to cagrilintide (-0.9%). 📊🔍
⚖️💪 Significant weight loss (-15.6%) vs semaglutide (-5.1%) & cagrilintide (-8.1%). 📉🏋️♂️
📉🔬⬇FPG reduction (-3.3 mmol/L) vs cagrilintide (-1.7 mmol/L)#GlucoseControl
⏰⚖️ CGM parameters improved: TIR (88.9%), vs cagrilintide (71.7%) vs semglutide (76.2%). ⌛️📊
👍🩺 Well-tolerated: Mild/moderate GI side effects reported, no severe hypoglycemia or fatal events. 💊👌
thelancet.com/journals/lance…
#ADA2023
Matthew Heppel retweeted
We unveiled our new #juniordoctors mess at Hull Royal Infirmary today, updated to provide comfortable modern surroundings for doctors in training to rest and relax. As well as seating, dining and kitchen areas, there are also 4 sleeping pods for those on-call/on shifts @PurvaDr
Matthew Heppel retweeted
My take on pharmacists managing health inequalities ..,,
diabetesonthenet.com/wp-cont…
#healthinequalities #pharmacists
Matthew Heppel retweeted
#pharmily #yorkshire - we are ACTUALLY bringing the i2i Clinical Summit to #Leeds! Spaces are limited - only 💯 places are booking fast! We will be covering vast array of topics and it will be unmissable for #GPPharmacists ! Pls RT for your northern colleagues. Sept 28th it is!
Matthew Heppel retweeted
Rant warning ⚠️
So I am a pharmacist and I am regulated by a professional body which I have to pay for to protect the public so I am asking, why can't we regulate MPs in the same way?
They should pay a % to be regulated. My professional body has a code of conduct
1/6 – at South West, England
Matthew Heppel retweeted
Chuffed with our abstract title at least 👍🏽 👍🏽
#Endocrinology #Graves
Matthew Heppel retweeted
A hard day at work eventually comes to an end.
A day living with #t1d sadly doesn’t.
One day I hope that will change…I hope 🤞
This is one example why #mentalhealth support is so important 🤝
#gbdoc #diabeteschat
Matthew Heppel retweeted
Advanced clinical pharmacist @KMedlinskiene is inspiring other pharmacists to carry out more research and truly involve patients and the public #PJWomen2Watch @HullHospitals @UniofBradford
pharmaceutical-journal.com/a…
Matthew Heppel retweeted
Find below 2 infographics from my joint presentation at @diabetespc 2022 with D&E pharmacist extraordinaire @Ines_VFonseca on the management of abnormal LFTs & NAFLD in PC
This is a very hot topic for us in PC but we also make a rod for our own backs by over-requesting LFTs!








































